HELICOBACTER

Abbr. HELICOBACTER ·UNITED STATES ·Frequency Quarterly ·Avg. articles/yr 74 articles

4.6

Latest IF

11.40%

Self-citation

一般

Submission difficulty

平均2月

Review cycle

About Journal

HELICOBACTER是一本专注于幽门螺杆菌及相关领域研究的国际学术期刊，其ISSN号为1083-4389，由美国出版商Wiley-Blackwell出版，出版地为美国，出版周期为双月刊。该期刊的影响因子根据年份有所不同，具体数值需查阅最新JCR报告，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区需参考最新分区表（通常为医学或微生物学领域的3区或4区）。杂志的发文特点集中于幽门螺杆菌的病原学、流行病学、诊断治疗及与胃肠道疾病关联的研究，涵盖基础与临床医学的交叉领域。其质量较高，审稿严格，但作为细分领域期刊，受众相对局限，可能存在投稿竞争激烈或发表周期较长的风险，适合从事相关领域的研究者投稿。

IF Trend

Recent Articles

Population‐Level Trends in Gastric Cancer Mortality and Incidence After Expansion of Japanese National Health Insurance Coverage for <scp> Helicobacter pylori </scp> Eradication: A Descriptive Time‐Trend Study 2026-09-08

Issue Information 2026-09-08

A Novel Helicobacter pylori Test Based on 16S rRNA Isothermal Amplification Point‐of‐Care Testing of Throat Swab 2026-09-08

10.1111/hel.v31.5 2026-09-08

Bismuth–Amoxicillin–Vonoprazan Triple, Amoxicillin–Vonoprazan Dual, and Clarithromycin‐Based Triple Therapies for First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Open‐Label, Randomized Trial 2026-08-25

14‐Day Vonoprazan–Minocycline Dual Therapy Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Single‐Center Randomized Controlled Noninferiority Trial 2026-08-20

Local Price and Clarithromycin Resistance Shape the Cost of Vonoprazan Triple Therapy for Helicobacter pylori Eradication 2026-08-20

School‐Based Helicobacter pylori Screening for Adolescents in Japan: Current Status, Challenges, and Implications: A Narrative Review 2026-08-16

Diagnostic Accuracy of Serum Antibody, Urine Antibody, and Stool Antigen Tests for Helicobacter pylori in Japan: A Systematic Review and Meta‐Analysis 2026-08-16

A Decade of Screening and Treating <scp> Helicobacter pylori </scp> Infection Among First‐Year High School Students in Kyoto, Japan: Annual Trends in Infection, Consultation, and Eradication Success Rates (2015–2023) 2026-08-16